[{"address1": "771 Jamacha Rd., #512", "city": "El Cajon", "state": "CA", "zip": "92019", "country": "United States", "phone": "619 596 8600", "website": "https://www.purebio.com", "industry": "Household & Personal Products", "industryKey": "household-personal-products", "industryDisp": "Household & Personal Products", "sector": "Consumer Defensive", "sectorKey": "consumer-defensive", "sectorDisp": "Consumer Defensive", "longBusinessSummary": "PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. Its technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. It serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. The company sells its products through end-use customers and third party distributors. The company was incorporated in 1992 and is based in El Cajon, California.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert F. Bartlett", "age": 78, "title": "President, CEO & Director", "yearBorn": 1945, "fiscalYear": 2024, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark Stuart Elliott", "age": 48, "title": "VP of Finance and Principal Financial & Accounting Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 180000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas Richard Myers", "age": 71, "title": "Executive VP of Technology & Development and Director", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Kitchell", "title": "VP of Operations & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tim  Steffensmeier", "title": "Vice President of Sales & Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.purebio.com/about/investor_relations", "maxAge": 86400, "priceHint": 4, "previousClose": 0.068, "open": 0.063, "dayLow": 0.063, "dayHigh": 0.069, "regularMarketPreviousClose": 0.068, "regularMarketOpen": 0.063, "regularMarketDayLow": 0.063, "regularMarketDayHigh": 0.069, "beta": 0.037, "volume": 33781, "regularMarketVolume": 33781, "averageVolume": 30676, "averageVolume10days": 52840, "averageDailyVolume10Day": 52840, "bid": 0.063, "ask": 0.07, "marketCap": 8216670, "fiftyTwoWeekLow": 0.06, "fiftyTwoWeekHigh": 0.16, "priceToSalesTrailing12Months": 4.185772, "fiftyDayAverage": 0.092, "twoHundredDayAverage": 0.08105, "currency": "USD", "enterpriseValue": 10429953, "profitMargins": -1.70657, "floatShares": 65708966, "sharesOutstanding": 111856000, "sharesShort": 222969, "sharesShortPriorMonth": 254799, "sharesShortPreviousMonthDate": 1364428800, "dateShortInterest": 1367280000, "sharesPercentSharesOut": 0.0182, "heldPercentInsiders": 0.41256002, "shortRatio": 2.56, "shortPercentOfFloat": 0.0186, "impliedSharesOutstanding": 117381000, "bookValue": -0.026, "lastFiscalYearEnd": 1722384000, "nextFiscalYearEnd": 1753920000, "mostRecentQuarter": 1722384000, "netIncomeToCommon": -3350000, "trailingEps": -0.03, "lastSplitFactor": "1:8", "lastSplitDate": 1344988800, "enterpriseToRevenue": 5.313, "enterpriseToEbitda": -3.496, "52WeekChange": -0.5333333, "SandP52WeekChange": 0.2764505, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "PURE", "underlyingSymbol": "PURE", "shortName": "PURE Bioscience", "longName": "PURE Bioscience, Inc.", "firstTradeDateEpochUtc": 839511000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "514def58-2a10-331d-b6cb-5a547dd55cf6", "messageBoardId": "finmb_385751", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.07, "recommendationKey": "none", "totalCash": 349000, "totalCashPerShare": 0.003, "ebitda": -2983000, "totalDebt": 2949000, "quickRatio": 0.883, "currentRatio": 1.098, "totalRevenue": 1963000, "revenuePerShare": 0.018, "returnOnAssets": -1.4808, "freeCashflow": -1437750, "operatingCashflow": -2531000, "revenueGrowth": -0.213, "grossMargins": 0.58686, "ebitdaMargins": -1.5196099, "operatingMargins": -1.3481, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-15"}]